Navigation Links
High-Flo™ Confirmed As "Safety Sets"
Date:6/8/2012

CHESTER, N.Y., June 8, 2012 /PRNewswire/ -- Results of an Active Controlled Clinical Simulated Use Study confirm that RMS High-Flo™ Subcutaneous Needle Sets are "safety sets," according to the manufacturer Repro-Med Systems, Inc., (REPR.PK) dba RMS Medical Products of Chester, N.Y. The U.S. Food and Drug Administration (FDA) has reviewed the protocol for the study. The needle sets are now known as RMS High-Flo™ Subcutaneous Safety Needle Sets.

"We had been confident from the beginning that the design of the butterfly wing closure on our High-Flo™ sets functionally encases the needle after use to protect against accidental needlesticks," said Andy Sealfon, President of RMS Medical Products. "Results of the study which encompassed more than 500 simulated administrations demonstrated there were no needlestick issues and no other safety issues," he added.    

Leading nurses, pharmacists and other infusion health professionals attending the March 2012 Annual Conference of the National Home Infusion Association (NHIA) in Phoenix, AZ, participated in the study. Participants were asked to insert and remove the infusion needles, using inanimate materials to substitute for portions of the human anatomy.

The medical community has focused on the prevention of needlestick injuries with many published studies showing the benefits of needle safety devices (i.e., The New England Journal of Medicine, Feb. 16, 2012: Phillips, Conway, and Jagger – Letter to Editor), and the continued significance of legislation such as the federal government's Needlestick Safety and Prevention Act (NSPA).

"Needlestick prevention is critical and we're excited to confirm this safety feature in our subcutaneous needle sets," Sealfon said. "High-Flo™ has been praised by patients for consistent needle tip sharpness, unrivaled flow performance, and outstanding comfort due, in part, to butterfly wings designed to prevent the needle from 'popping out' after insertion. The safety designation complements an already superior design for the patient and health professional," Sealfon concluded.

RMS High-Flo™ Subcutaneous Safety Needle Sets are available in a variety of needle lengths, gauges and configurations for infusions involving single or multiple sites.

RMS Medical Products, manufacturer of RMS High-Flo™ Subcutaneous Safety Needle Sets also is the manufacturer of the FREEDOM60® Syringe Infusion System and the RES-Q-VAC® hand powered suction device. A primary use for the FREEDOM60® Syringe Infusion Pump is in subcutaneous administration of immune globulin due to its safe, controlled pressure. The inherently safe pressures used to deliver drugs to patients minimize discomfort, swelling and other complications sometimes found with conventional electric infusion devices. There are additional applications such as the delivery of antibiotics for the ambulatory patient. The company is located at 24 Carpenter Road, Chester, NY 10918. For more information, visit http://www.rmsmedicalproducts.com

 

For further information:

Michelle DiGregorio, RMS Medical Products

e-mail: mdigregorio@rmsmedicalproducts.com

phone: (845) 469-2042, ext. 317


'/>"/>
SOURCE RMS Medical Products
Copyright©2012 PR Newswire.
All rights reserved

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
(Date:9/7/2017)... , Sept. 7, 2017 Caris Life ... on fulfilling the promise of precision medicine, today ... the benefits of its molecular profiling approach in ... comprehensive genomic profiling plus (CGP+) with Caris Molecular ... tumor on a molecular level, leading to more ...
(Date:9/7/2017)... --  BioLife Solutions , Inc. (NASDAQ: BLFS ), ... cell and tissue hypothermic storage and cryopreservation ... President and CEO, will be presenting at two investment conferences ... 19 th Annual Global Investment Conference on Tuesday, September ... The conference is being held at the New York Palace ...
Breaking Medicine Technology:
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... Illustrate, Maintain® methodology and industry-leading compliance software, The Guard®, has helped another long-time ... Rights (OCR) HIPAA audit and properly satisfy the law. , Thanks to the ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... and social campaign, “Humans With Vaginas.” The goal is to ignite conversation via ... non-toxic personal care products. The brand has declared September “Humans with Vaginas” month, ...
(Date:9/20/2017)... ... 20, 2017 , ... Medicare doesn’t have the authority to ... for their prescription drugs, according to a new comparison of drug plans by ... behalf, there’s no consistency in drug pricing among drug plans,” states TSCL’s Medicare ...
(Date:9/20/2017)... ... September 20, 2017 , ... “The Trials I Face to Receive ... he emotionally pens his aspirations and goals to better one’s life through God. “The ... Green, while searching in all the wrong places, found a love for writing. Green ...
(Date:9/20/2017)... ... September 20, 2017 , ... Houston, Texas, investment firm CORDA Investment ... 8, and Monday, September 11, off work and rolled up their sleeves to help ... to local homes to start the process of rebuilding. , CORDA founder Bonner C. ...
Breaking Medicine News(10 mins):